IOVS Journal of Pharmacology and Experimental Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:755-760.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.02-0340

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angeletti, B.
Right arrow Articles by Marigo, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angeletti, B.
Right arrow Articles by Marigo, V.

An In Vivo Doxycycline-Controlled Expression System for Functional Studies of the Retina

Barbara Angeletti,1,2 Jana Löster,2 Alberto Auricchio,1 Florian Gekeler,3 Kei Shinoda,3 Andrea Ballabio,1,4 Jochen Graw,2 and Valeria Marigo1

1From the Telethon Institute of Genetics and Medicine, Naples, Italy; the 2Laboratory of Molecular Eye Development, Research Center for Environment and Health, Institute of Mammalian Genetics, Neuherberg, Germany; the 3Department of Pathophysiology of Vision and Neuro-Ophthalmology, University Eye Hospital, Tübingen, Germany; and the 4Department of Medical Genetics, Second University of Naples, Naples, Italy.

PURPOSE. Transgenic mice were developed that express tetracycline-controlled transactivator 1 (tTA1) specifically in photoreceptor cells. In these mice the transcription of the gene of interest can be easily inactivated in the retina in a short time frame.

METHODS. A construct was prepared containing tTA1 under control of the murine rhodopsin regulatory region. This construct was used for the generation of transgenic mice. In situ hybridization was performed to study the distribution of the transactivator in the retina. The activity of the transactivator was analyzed by mating the lines with a luciferase reporter transgenic mouse. tTA1 activity and doxycycline’s ability to block it were analyzed by luciferase assay. The effects of tTA1 on the retina were assessed by histology and electrophysiology.

RESULTS. Two transgenic lines were developed that specifically express tTA1 in photoreceptor cells. The time course of transgene expression replicated transcription of endogenous rhodopsin. tTA1 was not toxic to the retina. Transactivator activity was blocked readily by doxycycline.

CONCLUSIONS. An expression system for photoreceptor cells was generated to drive transcription in a cell-specific and time-controllable manner. This system is suitable for the study of factors involved in retinal biology and of mutant forms of genes involved in retinal diseases.





This article has been cited by other articles:


Home page
IOVSHome page
Y.-Z. Le, W. Zheng, P.-C. Rao, L. Zheng, R. E. Anderson, N. Esumi, D. J. Zack, and M. Zhu
Inducible Expression of Cre Recombinase in the Retinal Pigmented Epithelium
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1248 - 1253.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Dalke, J. Loster, H. Fuchs, V. Gailus-Durner, D. Soewarto, J. Favor, A. Neuhauser-Klaus, W. Pretsch, F. Gekeler, K. Shinoda, et al.
Electroretinography as a Screening Method for Mutations Causing Retinal Dysfunction in Mice
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 601 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology